Categories Earnings Calls, Health Care

Biogen, Inc. (BIIB) Q4 2020 Earnings Call

Biogen, Inc. (NASDAQ: BIIB) Q4 2020 earnings call dated Feb. 03, 2021

Corporate Participants:

Mike Hencke — Director, Investor Relations

Michel Vounatsos — Chief Executive Officer

Alfred W. Sandrock — Executive Vice President

Michael McDonnell — Executive Vice President Chief Financial Officer

Analysts:

Max Skor — Morgan Stanley — Analyst

Terence Flynn — Goldman Sachs — Analyst

Marc Goodman — SVB Leerink — Analyst

Umer Raffat — Evercore — Analyst

Cory Kasimov — JPMorgan — Analyst

Evan Seigerman — Credit Suisse — Analyst

Michael Yee — Jefferies — Analyst

Paul Matteis — Stifel — Analyst

Phil Nadeau — Cowen & Company — Analyst

Jay Olson — Oppenheimer — Analyst

Robyn Karnauskas — Truist — Analyst

Salim Syed — Mizuho — Analyst

_________
To read the full earnings call transcript, click here

Most Popular

Hormel (HRL) expects earnings pressure to continue into Q1 2026

Shares of Hormel Foods Corporation (NYSE: HRL) gained over 3% on Thursday. The company delivered mixed results for the fourth quarter of 2025, as earnings came ahead of expectations while

Key metrics from Kroger’s (KR) Q3 2025 earnings results

The Kroger Co. (NYSE: KR) reported its third quarter 2025 earnings results today. Total company sales rose to $33.9 billion from $33.6 billion in the same period last year. Identical

Dollar General (DG) Q3 2025 Earnings: Key financials and quarterly highlights

Dollar General Corporation (NYSE: DG) reported its third quarter 2025 earnings results today. Net sales increased 4.6% year-over-year to $10.65 billion. Same-store sales increased 2.5%. Net income was $282.7 million, or

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top